Overcoming hurdles to cancer immune response: cell therapies, cancer vaccine development and combination therapies
Returning on the 27th & 28th September 2017 for strategic direction on preclinical development of vaccines and new approaches. LONDON, UNITED KINGDOM, April 27, 2017 /EINPresswire.com/ -- SMi Reports: Widely recognised as one of the most profitable …